Atrovenetin

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Antibiotics
Catalog number BBF-00130
CAS
Molecular Weight 342.34
Molecular Formula C19H18O6

Online Inquiry

Description

Atrovenetin is an antibiotic produced by Penicillum herquei PRL 1838 and Pen. atrovenetum SM 683.

Properties

Appearance Yellow orange rectangular Flake
Boiling Point 648.4°C at 760 mmHg
Melting Point 295°C (dec.)
Density 1.471 g/cm3
Solubility Soluble in Acetone, Acetic acid, Dioxane

Reference Reading

1. Geranylgeranylation but not GTP loading determines rho migratory function in T cells
Sonia Waiczies, Ivo Bendix, Timour Prozorovski, Maya Ratner, Irina Nazarenko, Caspar F Pfueller, Alexander U Brandt, Josephine Herz, Stefan Brocke, Oliver Ullrich, Frauke Zipp J Immunol. 2007 Nov 1;179(9):6024-32. doi: 10.4049/jimmunol.179.9.6024.
Rho GTPases orchestrate signaling pathways leading to cell migration. Their function depends on GTP loading and isoprenylation by geranylgeranyl pyrophosphate (GGpp). In this study, we show that in human T cells, geranylgeranylation-and not GTP loading-is necessary for RhoA-mediated downstream events. As a result of GGpp depletion with the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin, RhoA was sequestered from the membrane to the cytosol and, notwithstanding increased GTP loading, the constitutive activation of its substrate Rho-associated coiled-coil protein kinase-1 was blocked. In line with this, T cells expressing increased GTP-RhoA failed to form an intact cytoskeleton and to migrate toward a chemokine gradient. In vivo treatment with atorvastatin in the rodent model of multiple sclerosis markedly decreased the capacity of activated T cells to traffic within the brain, as demonstrated by multiphoton analysis. Thus, tethering of RhoA to the membrane by GGpp is determinant for T cell migration and provides a mechanism for preventing T cell infiltration into inflamed compartments by 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors.
2. Effect of chloroform and aqueous basic fraction of ethanolic extract from Apium graveolens L. in experimentally-induced hyperlipidemia in rats
Deepa Iyer, U K Patil J Complement Integr Med. 2011 Sep 27;8:/j/jcim.2011.8.issue-1/1553-3840.1529/1553-3840.1529.xml. doi: 10.2202/1553-3840.1529.
The present study was undertaken to explore the antihyperlipidemic effect of ethanolic extract of seeds of Apium graveolens L. and its chloroform and aqueous basic fraction in olive oil induced hyperlipidemic rats. The antihyperlipidemic activity of Apium graveolens was compared with a standard drug Atrovastatin (50mg/kg). The study involved phytochemical screening and chromatographic studies of extract and fractions. The ethanolic extract and its fractions were administered orally at doses of 200 and 400 mg/kg body weight in rats. Olive oil (5ml/kg oral dose) was administered 30 min after treatment. Blood was collected by ocular puncture 2 and 4 h after olive oil treatment and centrifuged at 3000 rpm for 15-20 min. Serum samples were further subjected to biochemical analysis. The study dose dependently inhibited the total cholesterol (TC) triglycerides (TG), low density lipoproteins (LDL) level, and significantly increased high density lipoprotein (HDL) level. Phytochemical screening revealed the presence of terpenoid, tannin, alkaloid, glycoside, flavanoid and sterols. UV λmax was found to be 206 nm with a melting point of 137-138°C for the isolated component. The antihyperlipidemic effect was evaluated in olive oil loaded rats. Acute treatment caused stimulatory effect on HDL level and inhibition in TC and TG elevation induced by olive oil.
3. Effect of statin use in patients with acute coronary syndromes and a serum low-density lipoprotein
Thomas T Tsai, Brahmajee K Nallamothu, Debabrata Mukherjee, Melvyn Rubenfire, Jianming Fang, Paul Chan, Eva Kline-Rogers, Amisha Patel, David F Armstrong, Kim A Eagle, A D Goldberg Am J Cardiol. 2005 Dec 1;96(11):1491-3. doi: 10.1016/j.amjcard.2005.07.069. Epub 2005 Oct 11.
We identified 155 patients who were admitted with an acute coronary syndrome and a low-density lipoprotein cholesterol level

Recommended Products

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Verification code

Copyright © 2024 BOC Sciences. All rights reserved.

cartIcon
Inquiry Basket